U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C34H38Cl2FN3O4
Molecular Weight 642.588
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ALRIZOMADLIN

SMILES

CCN1[C@H]([C@H](C2=C(F)C(Cl)=CC=C2)[C@]3(C(=O)NC4=C3C=CC(Cl)=C4)C15CCCCC5)C(=O)NC67CCC(CC6)(CC7)C(O)=O

InChI

InChIKey=YJCZPJQGFSSFOL-MNZPCBJKSA-N
InChI=1S/C34H38Cl2FN3O4/c1-2-40-27(28(41)39-32-16-13-31(14-17-32,15-18-32)30(43)44)25(21-7-6-8-23(36)26(21)37)34(33(40)11-4-3-5-12-33)22-10-9-20(35)19-24(22)38-29(34)42/h6-10,19,25,27H,2-5,11-18H2,1H3,(H,38,42)(H,39,41)(H,43,44)/t25-,27+,31?,32?,34+/m0/s1

HIDE SMILES / InChI

Molecular Formula C34H38Cl2FN3O4
Molecular Weight 642.588
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 3 / 3
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Thu Jul 06 17:19:12 UTC 2023
Edited
by admin
on Thu Jul 06 17:19:12 UTC 2023
Record UNII
15QAU0SI9J
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ALRIZOMADLIN
INN  
Official Name English
BICYCLO(2.2.2)OCTANE-1-CARBOXYLIC ACID, 4-((((3'R,4'S,5'R)-6''-CHLORO-4'-(3-CHLORO-2-FLUOROPHENYL)-1'-ETHYL-1'',2''-DIHYDRO-2''-OXODISPIRO(CYCLOHEXANE-1,2'-PYRROLIDINE-3',3''-(3H)INDOL)-5'-YL)CARBONYL)AMINO)-
Systematic Name English
APG 115 [WHO-DD]
Common Name English
alrizomadlin [INN]
Common Name English
APG-115
Code English
(3'R,4'S,5'R)-4-((6-CHLORO-2-OXO-1,2-DIHYDRO-SPIRO(INDOLE-3,3'-PYRROLIDIN)E-4'-(3-CHLORO-2-FLUORO -PHENYL)-1'-ETHYL-SPIRO(CYCLOHEXANE-1,2'-PYRROLIDINE)-5'-CARBONYL)-AMINO)-BICYCLO(2.2.2)OCTANE-1-CARBOXYLIC ACID
Common Name English
AA-115
Code English
Classification Tree Code System Code
FDA ORPHAN DRUG 763020
Created by admin on Thu Jul 06 17:19:12 UTC 2023 , Edited by admin on Thu Jul 06 17:19:12 UTC 2023
FDA ORPHAN DRUG 778720
Created by admin on Thu Jul 06 17:19:12 UTC 2023 , Edited by admin on Thu Jul 06 17:19:12 UTC 2023
FDA ORPHAN DRUG 745620
Created by admin on Thu Jul 06 17:19:12 UTC 2023 , Edited by admin on Thu Jul 06 17:19:12 UTC 2023
FDA ORPHAN DRUG 762520
Created by admin on Thu Jul 06 17:19:12 UTC 2023 , Edited by admin on Thu Jul 06 17:19:12 UTC 2023
FDA ORPHAN DRUG 826021
Created by admin on Thu Jul 06 17:19:12 UTC 2023 , Edited by admin on Thu Jul 06 17:19:12 UTC 2023
FDA ORPHAN DRUG 869522
Created by admin on Thu Jul 06 17:19:12 UTC 2023 , Edited by admin on Thu Jul 06 17:19:12 UTC 2023
FDA ORPHAN DRUG 784720
Created by admin on Thu Jul 06 17:19:12 UTC 2023 , Edited by admin on Thu Jul 06 17:19:12 UTC 2023
Code System Code Type Description
PUBCHEM
91972012
Created by admin on Thu Jul 06 17:19:12 UTC 2023 , Edited by admin on Thu Jul 06 17:19:12 UTC 2023
PRIMARY
NCI_THESAURUS
C132991
Created by admin on Thu Jul 06 17:19:12 UTC 2023 , Edited by admin on Thu Jul 06 17:19:12 UTC 2023
PRIMARY
CAS
1818393-16-6
Created by admin on Thu Jul 06 17:19:12 UTC 2023 , Edited by admin on Thu Jul 06 17:19:12 UTC 2023
PRIMARY
SMS_ID
300000039054
Created by admin on Thu Jul 06 17:19:12 UTC 2023 , Edited by admin on Thu Jul 06 17:19:12 UTC 2023
PRIMARY
FDA UNII
15QAU0SI9J
Created by admin on Thu Jul 06 17:19:12 UTC 2023 , Edited by admin on Thu Jul 06 17:19:12 UTC 2023
PRIMARY
INN
11788
Created by admin on Thu Jul 06 17:19:12 UTC 2023 , Edited by admin on Thu Jul 06 17:19:12 UTC 2023
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
Blocks the MDM2−p53 interaction, liberates the tumor suppressor function of p53
Ki
Related Record Type Details
ACTIVE MOIETY